Threatened Abortion in First Trimester
4
Pipeline Programs
1
Companies
1
Clinical Trials
3
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
3
Early DiscoveryClinical DevelopmentMarket
On Market (3)
Approved therapies currently available
U
PROGESTASERTApproved
progesterone
Unknown Companyintrauterine1976
U
PROGESTERONEApproved
progesterone
Unknown CompanyProgesterone [EPC]oral2017
U
PROMETRIUMApproved
progesterone
Unknown Companyoral1998
Competitive Landscape
1 companies ranked by most advanced pipeline stage
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
1 program1
ProgesteronePhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
IBSA Institut BiochimiqueProgesterone
Clinical Trials (1)
Progesterone in Threatened Abortion
Start: Apr 2017Est. completion: May 2018
Phase 3Terminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space